Page results
-
UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Today, 11 February, marks the tenth anniversary of the International Day of Women and Girls in Science, which seeks to bring gender equality in science and promote role models to inspire girls and women into scientific professions.
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
A new toolkit to support babies, children and young people in healthcare access high quality health play services was launched at UCLH last week with UCLH chief nurse Vanessa Sweeney welcoming visitors from NHS England and the play charity Starlight.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.
-
This information is for patients receiving steroids for immunotherapy toxicity.
File results
-
FOI/2022/0050 - Patients on a waiting list for Tier 4 weight management services
-
FOI/2022/0052 - Makes/ models of plasma thawer used in Pathology/ transfusion
-
FOI/2022/0062 - Vehicle fleet information and governance
-
FOI/2022/0064 - Neonatal visiting policy/ visitation rights
-
FOI/2022/0068 - Staff and covid vaccinations
-
FOI/2022/0070 - Viscosupplementation use and spend
-
FOI/2022/0071 - Sodium Hyaluronate eye drops
-
FOI/2022/0076 - Private patient third party involvement
-
FOI/2022/0080 - Bariatric equipment
-
FOI/2022/0083 - Estates and inrastructure failures